General Information of Disease (ID: DISNFI3F)

Disease Name Insulin-dependent diabetes
Disease Class 5A10: Diabetes mellitus
Disease Hierarchy
DIS01GPL: Grass pollen hypersensitivity
DISNFI3F: Insulin-dependent diabetes
ICD Code
ICD-11
ICD-11: 5A10
Expand ICD-11
'5A10
Expand ICD-10
'E10; 'E10.0; 'E10.1; 'E10.2; 'E10.3; 'E10.4; 'E10.5; 'E10.6; 'E10.7; 'E10.8; 'E10.9
Disease Identifiers
MONDO ID
MONDO_0010255
UMLS CUI
C1848042
OMIM ID
300136
MedGen ID
338376

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 5 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
DiabeCell DMK6FYR Phase 2 NA [1]
HinsBet DM97A5O Phase 2 NA [2]
SAR292833 DM63QY0 Phase 2 NA [3]
Insulin B chain vaccine DMEQVTK Phase 1 NA [4]
NN-1952 DMQO0NC Phase 1 NA [5]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 3 Discontinued Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
AnergiX-IDDM DMNCH8Q Terminated NA [6]
AnervaX.DB DM894X9 Terminated NA [7]
NNC-55-0118 DMC451S Terminated Small molecular drug [8]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 13 Investigative Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
CPG23DIAB DMXR7E8 Investigative NA [3]
CPG23STEM DMBB93I Investigative NA [3]
EDC/IL-4 DMZBJ2Y Investigative NA [3]
EDP-10 DM0FWQE Investigative NA [3]
Epi-13 DMLGP4I Investigative NA [3]
FT-201 DM4SJW8 Investigative NA [3]
GlucoStem DMN05SZ Investigative NA [3]
GRNIC-1 DM9YVDZ Investigative NA [3]
MCT-275 DMEQCQU Investigative NA [3]
MesoStem DMALRXV Investigative NA [3]
ReN-002 DM7Y8DZ Investigative NA [3]
RGI-3010 DM20TUF Investigative NA [3]
WIT-301 DM3U5BJ Investigative NA [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 13 Drug(s)

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1 ClinicalTrials.gov (NCT01736228) Open-label Investigation of the Safety and Efficacy of DIABECELL in Patients With Type 1 Diabetes Mellitus. U.S. National Institutes of Health.
2 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800034744)
3 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
4 Prevention of Type 1 Diabetes Mellitus using a Novel Vaccine. Ther Adv Endocrinol Metab. 2011 Feb;2(1):9-16.
5 ClinicalTrials.gov (NCT01028404) A Two Part Trial Investigating NN1952 in Healthy Subjects and Subjects With Type 1 and Type 2 Diabetes. U.S. National Institutes of Health.
6 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014923)
7 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010394)
8 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010228)